IL2 and COVID-19: Both studies uniformly describe stable cellular immune responses against SARS-CoV-2 including IFN-γ release as does our study but also of other cytokines (IL-2, IL-4, TNF-α etc.)and proliferation assays in SOT convalescents similar to non-IS-Con up to twelve months after COVID-19.